1-4 of 4
Peter W. McLaughlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bone Loss in Patients with Previously Untreated Lymphoma: The Effect of Periodontal Disease on the Use of Zoledronic Acid

Free
Vince D. Cataldo, M.D., Michael A. Thompson, M.D., PhD, Bela B. Toth, D.D.S., Perpetua Sanjorjo, B. Nebiyou Bekele, PhD, Camilo Jimenez, M.D., William A. Murphy, M.D., Auris O. Huen, Pharm.D., Rebecca B. Arbuckle, Pharm.D., Michelle A. Fanale, M.D., Luis E. Fayad, M.D., Nathan Fowler, M.D., Larry W. Kwak, M.D., Peter W. McLaughlin, M.D., Sattva S. Neelapu, M.D., Barbara Pro, M.D., Alma Rodriguez, M.D., Jatin Shah, M.D., Fredrick B. Hagemeister, M.D.
Journal: Blood
Blood (2008) 112 (11): 5297.
https://doi.org/10.1182/blood.V112.11.5297.5297
Published: 2008
Journal Articles

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Free
Amin M. Alousi, MD, Chitra Hosing, M.D., Rima M. Saliba, PhD., Rosamar B. Valverde, BSN, Farzaneh Maadani, BS, Martin Korbling, M.D., Grace J. Okoroji, MS, Luis E. Fayad, M.D., Anne M. Stachowiak, BS, William D. Erwin, MS, Paolo Anderlini, M.D., Marcos J. de Lima, M.D., Sergio A. Giralt, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Naoto T. Ueno, M.D., Peter W. McLaughlin, M.D., Barbara Pro, M.D., Michael Wang, M.D., Alma Rodriguez, M.D., Fredrick B. Hagemeister, M.D., Homer A. Macapinlac, M.D., Donald A. Podoloff, M.D., Richard E. Champlin, M.D., Issa F. Khouri, M.D.
Journal: Blood
Blood (2007) 110 (11): 620.
https://doi.org/10.1182/blood.V110.11.620.620
Published: 2007
Journal Articles

Efficacy and Safety of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

Free
Issa F. Khouri, MD, Rima M. Saliba, PHD, Chitra Hosing, MD, Rosamar Valverde, RN, William D. Erwin, MS, Luis Fayad, MD, Farzaneh Maadani, BS, Martin J. Korbling, MD, Grace-Julia Okoroji, MS, Anne M. Stachowiak, BS, Barry I. Samuels, MD, Paolo Anderlini, MD, Daniel R. Couriel, MD, Marcos de Lima, MD, Sergio Giralt, MD, Uday Popat, MD, Partow Kebriaei, MD, Naoto T. Ueno, MD, Muzaffar H. Qazilbash, MD, Peter W. McLaughlin, MD, Fredrick B. Hagemeister, MD, Anas Younes, MD, Donald A. Podoloff, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2006) 108 (11): 315.
https://doi.org/10.1182/blood.V108.11.315.315
Published: 2006
Journal Articles

Autologous Stem Cell (AUTO) vs Non-Myeloablative Allogeneic Transplantation (NMT) after High-Dose Rituximab (HD-R) -Containing Conditioning Regimens for Relapsed Chemosensitve Follicular Lymphoma (FL).

Free
Issa F. Khouri, MD, Rima M. Saliba, PhD, Chitra M. Hosing, MD, Sandra A. Acholonu, MPH, Luis E. Fayad, MD, Martin J. Korbling, MD, Celina Saenz, BS, Barbara Pro, MD, Barry I. Samuels, MD, Marcos J. de Lima, MD, Sergio A. Giralt, MD, Anas Younes, MD, Peter W. McLaughlin, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2005) 106 (11): 48.
https://doi.org/10.1182/blood.V106.11.48.48
Published: 2005